Senzime Secures New Contract With Leading US Healthcare System
UPPSALA, SWEDEN / ACCESSWIRE / September 24, 2024 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured an initial...
Healthcare
Ainos Spotlighted in Water Tower Research Report on VELDONA Clinical Study for Sjogren’s Syndrome
Sjogren's Syndrome is a rare autoimmune disease with limited treatment optionsPrior U.S. Phase 3 data demonstrated benefitsSAN DIEGO, CA /...
CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
This press release replaces the release issued today at 9:15am EDT.Revolutionary AI-driven cheek swab test poised to transform early cancer...
Safe Supply Streaming Sees Investor Interest Surge Following Safety Strips’ CEO Interview on Fentanyl- Fighting Stocks
Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) is pleased to see heightened...
DirectTrust(R) Releases New 2025 Accreditation Criteria Versions for Public Review Through November 22
Criteria updates include new Digital Therapeutics program criteria, new HIPAA and Maryland reproductive health regulations, FTC breach reporting rules, and...
SpendMend Welcomes Michael Williams as Leader in Healthcare Contract Services Solutions
GRAND RAPIDS, MI / ACCESSWIRE / September 24, 2024 / SpendMend, the leading provider of cost-cycle management solutions for the...
Tigerlily Foundation’s Annual Empower Ball: An Evening of Recognizing Impact in Health Equity, Empowerment and Transformation
WASHINGTON, DC / ACCESSWIRE / September 24, 2024 / Tigerlily Foundation proudly announces its Annual EmPOWER Ball, an evening dedicated...
GenHealth.ai Unveils Large Medical Model, Surpassing Industry Benchmarks by Over 14% in Healthcare Cost and Risk Prediction
Revolutionizing Healthcare with Generative AI: A New Standard for Precision in Patient Care ForecastingBOSTON, MA / ACCESSWIRE / September 24,...
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ETContinued progress within...
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”
TRxADE Health, Inc. today announced that it changed its name and ticker symbol to “Scienture Holdings, Inc.” and “SCNX”, respectively,...
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
DALLAS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence...
Araris Biotech AG Expands its IP Portfolio with the Acquisition of Innate Pharma’s Portfolio of Transglutaminase Patents for the Generation of Antibody-Drug Conjugates (ADCs)
Araris Biotech AG Expands its IP Portfolio with the Acquisition of Innate Pharma’s Portfolio of Transglutaminase Patents for the Generation...
Milestone Pharmaceuticals to Host Investor KOL Event
Learnings from the Field: Managing PSVT and Studying AFib-RVR in the Community Setting Hosted 10 am ET, Tuesday, October 8,...
Noom Calls for Affordable Choices and Fair Pricing of Weight-Loss Medications Ahead of Tuesday’s Senate Testimony
Noom will submit an official statement to the congressional record at Tuesday’s Senate hearing with three specific recommendations calling for...
Coave Therapeutics to Present Novel Data Highlighting the Potential of its ALIGATER™ Platform to Enhance the Targeted Delivery of Genetic Medicines at Upcoming Conferences
Paris, France, September 24, 2024 – Coave Therapeutics (‘Coave’), a genetic medicine company pioneering therapies for eye and neurodegenerative diseases,...
Oxford-Harrington Rare Disease Centre to Host Symposium on Pioneering Research and Innovation in Rare Disease Treatments
OXFORD, UK and CLEVELAND, Ohio, US, 24th September 2024 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the...
Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of Insomnia
The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including...
Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis
Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
Huawei Calls to Expand Partnerships to Drive Global Digital Inclusion through TECH4ALL
SHANGHAI, Sept. 24, 2024 /PRNewswire/ -- At the TECH4ALL Digital Inclusion Forum hosted at Huawei Connect 2024, Huawei called for more...
Compliancy Group Releases Texas HB 300 Program
NEW YORK, Sept. 24, 2024 /PRNewswire/ -- Compliancy Group releases the Texas HB 300 program, including policy templates and program...